Lincoln Pharmaceuticals Ltd vs Rpg Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 618 as of 17 Feb 16:01 . The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 yearsThe P/E Ratio of RPG Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 yearsThe Market Cap of RPG Life Sciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Lincoln Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 181.47 crore. This represent the decline of -100% The revenue of RPG Life Sciences Ltd for the Mar '26 is ₹ 190.39 crore as compare to the Dec '25 revenue of ₹ 183.44 crore. This represent the growth of 3.79% The ebitda of Lincoln Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 38.74 crore. This represent the decline of -100% The ebitda of RPG Life Sciences Ltd for the Mar '26 is ₹ 46.33 crore as compare to the Dec '25 ebitda of ₹ 34.75 crore. This represent the growth of 33.32% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of RPG Life Sciences Ltd changed from ₹ 34.93 crore to ₹ 29.9 crore over 6 quarters. This represents a CAGR of -9.85% The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 29.77 % on March 2021 to 21.66 % on March 2025 . This represents a CAGR of -6.16% over 5 years .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About RPG Life Sciences Ltd

RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or RPG Life Sciences Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 1,366 Cr while Market cap of RPG Life Sciences Ltd is 3,837 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd?

As of May 5, 2026, the Lincoln Pharmaceuticals Ltd stock price is INR ₹682.1. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2320.5.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.